John Beeler, Ph.D., SVP of Business Development at BPGbio, brings over two decades of experience in biotechnology and business development, with extensive expertise in novel therapeutics. Before ...

Tennessee has become the fourth state to prohibit insurance companies from funding organ transplants if the body parts come from China.

Previous skepticism turns to optimism as the first clinical trials for transplantation with genetically edited pig kidneys ...

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that Great Place to Work® and Fortune magazine recognized the company as one of the Fortune 100 Best ...

Key to 400-employee Denali's submission is the FDA allowing measurement of a type of GAG, called heparan sulfate, in ...

We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a ...

The lHonorBrige lawsuit, filed March 11 in federal court for the Eastern District of N.C., was prompted by CMS agreeing on ...

Regulus Therapeutics Inc.’s RGLS share price has surged by 12.00%, which has investors questioning if this is right time to sell.

Satish Nadig, MD, PhD,was recruited to lead Chicago-based Northwestern Medicine’s Comprehensive Transplant Center in 2021. At the same time, Dr. Nadig, who serves as transplant center director and ...

MEPSGEN US Inc., a global innovator in scalable nanoparticle production technology, announced today the launch of NanoCaliburtm, a cutting-edge, scalable nanoparticle (NP) production system in the ...

BEIJING, CHINA / ACCESS Newswire / March 31, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company focused on developing and ...

In accordance with the NMPA approval, Gyre intends to pursue an adaptive Phase 2/3 clinical trial design, combining dose exploration with efficacy confirmation, to efficiently evaluate pirfenidone's ...